NeuroPace Inc

NASDAQ:NPCE 4:00:00 PM EDT

13.30

-0.17 (-1.26%)

7:03:16 PM EDT: $13.00 -0.30 (-2.26%)

Market Cap (Intraday)	381.98M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$17.33 Million
Adjusted EPS	-$0.32

See more estimates

10-Day MA	$13.56
50-Day MA	$13.91
200-Day MA	$10.27

See more pivots

NeuroPace Inc Stock, NASDAQ:NPCE

455 North Bernardo Avenue, Mountain View, California 94043

United States of America

Phone: +1.650.237.2700

Number of Employees: 171

http://www.neuropace.com

Description

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.